https://www.thermofisher.com/antibody/product/GM-CSF-Antibody-clone-MP122E9-Monoclonal/MA5-23799
GM-CSF Monoclonal Antibody (MP122E9) | Invitrogen (MA5-23799)
Detect GM-CSF in ELISA, WB, Flow, Neu, IHC (P). Reacts with Rabbit, Rat, Mouse, Goat, Sheep. Cited in 1 publication. Advanced verification by Neutralization....
gm csfmonoclonal antibodyinvitrogenma5
https://www.medicaldaily.com/gm-csf-required-immune-attack-multiple-sclerosis-237033
GM-CSF required for the immune attack in multiple sclerosis
Apr 25, 2011 - The neutralization of the cytokine GM-CSF could halt the development of multiple sclerosis. This was demonstrated by the research team of the immunologist...
gm csffor theimmune attackrequiredmultiple
https://cancer.ca/en/cancer-information/resources/glossary/g/granulocytemacrophage-colonystimulating-factor-gmcsf
granulocyte-macrophage colony-stimulating factor (GM-CSF) | Canadian Cancer Society
A substance that stimulates the bone marrow to develop white blood cells (especially granulocytes and macrophages). These white blood cells help defend the...
colony stimulating factorgm csfgranulocytemacrophagecanadian
https://www.science20.com/news_articles/blocking_gmcsf_protein_may_prevent_smokinginduced_copd
Blocking GM-CSF Protein May Prevent Smoking-Induced COPD | Science 2.0
Blocking the protein Granulocyte macrophage-colony stimulating factor (GM-CSF) can reduce or prevent cigarette smoke-induced lung inflammation in mice and may...
gm csf
https://www.rch.org.au/specimen-collection/GM-CSF_Hypersensitivity_Assay/
Specimen Collection : GM-CSF Hypersensitivity Assay
specimen collectiongm csfhypersensitivityassay
https://www.thermofisher.com/order/catalog/product/BMS612TEN/faqs
Mouse GM-CSF ELISA Kit - FAQs
Find here a list of FAQs for Mouse GM-CSF ELISA Kit
gm csfelisa kitmousefaqs
https://pmc.ncbi.nlm.nih.gov/articles/PMC11550524/
Repeated inhalation of GM-CSF by nonhuman primates induces bronchus-associated lymphoid tissue...
Repeated inhalation of granulocyte-macrophage colony-stimulating factor (GM-CSF) was recently approved in Japan as a treatment for autoimmune pulmonary...
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2020.01625/full
Frontiers | Anti-PD-1 Immunotherapy Combined With Stereotactic Body Radiation Therapy and GM-CSF as...
Keywords: immunotherapy1, radiotherapy2, PD-L13, esophageal squamous cell carcinoma4, GM-CSF5.Esophageal squamous cell carcinoma (ESCC) is a lethal malignanc...
https://www.gsk.com/en-gb/media/press-releases/gsk-presents-new-efficacy-and-safety-data-of-an-anti-gm-csf-antibody-in-patients-with-rheumatoid-arthritis/
GSK presents new efficacy and safety data of an anti GM-CSF antibody in patients with rheumatoid...
Marked patient benefit observed in phase II study supports further clinical development of GSK3196165 for RA.
https://www.cancer.gov/research/participate/clinical-trials/intervention/allogeneic-gm-csf-secreting-breast-cancer-vaccine-sv-br-1-gm
Clinical Trials Using Allogeneic GM-CSF-secreting Breast Cancer Vaccine SV-BR-1-GM - NCI
NCI supports clinical trials that test new and more effective ways to treat cancer. Find clinical trials studying allogeneic gm-csf-secreting breast cancer...
https://www.wikidata.org/wiki/Q73438122
Expression of serum- and glucocorticoid-regulated kinase (sgk) mRNA is up-regulated by GM-CSF and...
scientific article published on 01 February 2000
https://elifesciences.org/articles/102659/peer-reviews
Peer review in Reprogramming of GM-CSF-dependent alveolar macrophages through GSK3 activity...
Chemical inhibition or genetic downregulation of glycogen synthase kinase-3 reprograms human monocyte-derived macrophages by enhancing their anti-inflammatory,...
https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-of-naxitamab-and-gm-csf-for-high-risk-neuroblastoma
A trial of naxitamab and GM-CSF for high risk neuroblastoma | Cancer Research UK
This trial is looking at naxitamab with GM-CSF to treat neuroblastoma that has continued to grow during treatment or has come back afterwards.
https://www.jci.org/articles/view/27745/figure/1
JCI - CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector...
https://www.prnewswire.com/news-releases/i-mab-reports-interim-results-from-part-1-study-for-anti-gm-csf-antibody-tjm2-to-treat-covid-19-patients-with--cytokine-release-syndrome-301066451.html
I-Mab Reports Interim Results from Part 1 Study for Anti-GM-CSF Antibody TJM2 to Treat COVID-19...
/PRNewswire/ -- I-Mab (NASDAQ: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of novel...